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Abstract 23 
 24 
Abstract 25 
Antiviral RNA-mediated silencing (RNAi) acts as a powerful innate immunity 26 
defence in plants, invertebrates and mammals. In C. elegans RNAi is systemic, i. e. 27 
RNAi silencing signals can move between cells and tissues. Furthermore RNAi 28 
effects can be inherited transgenerationally and may last for many generations. 29 
Neither the biological relevance of systemic RNAi nor transgenerational RNAi are 30 
currently understood. Here we examined the role of both pathways to protect 31 
C. elegans from viral infection. We studied the Orsay virus, a positive strand RNA 32 
virus related to Nodaviridae, and the first and only virus known to infect C. elegans. 33 
Immunity to Orsay virus infection requires the RNAi pathway. Surprisingly, we found 34 
that genes required for systemic or transgenerational RNAi did not have a role in 35 
antiviral defence. Furthermore, we found that Orsay virus infection did not elicit a 36 
systemic RNAi response even when a target for RNAi was provided using transgenes. 37 
Finally, we show that viral siRNAs, the effectors of RNAi, are not inherited to a level 38 
that provides any significant resistance to viral infection in the next generation. We 39 
conclude that systemic or transgenerational RNAi does not play a role in the defence 40 
to natural Orsay virus infection. Furthermore, our data suggest that there is a 41 
qualitative difference between experimental RNAi and antiviral RNAi. Our data are 42 
consistent with a model of systemic and transgenerational RNAi that requires a 43 
nuclear or germline component which is lacking in almost all RNA virus infections. 44 
 45 
Importance 46 
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Since its discovery in Caenorhabditis elegans, RNAi has proven a valuable scientific 47 
tool in many organisms. In C. elegans exogenous RNAi spreads throughout the entire 48 
organism and can be passed between generations, however there has been controversy 49 
as to the endogenous role/s that the RNAi pathway plays. One endogenous role for 50 
which spreading both within the infected organism and between generations would be 51 
advantageous is a role in viral defence. In plants antiviral RNAi is systemic, and the 52 
spread of RNAi between cells provides protection against subsequent viral infection. 53 
Here we investigate this using the only naturally occurring virus known to infect 54 
C. elegans, Orsay virus, and surprisingly find that in contrast to the exogenous RNAi 55 
pathway, the antiviral RNAi response targeted against this virus does not spread 56 
systemically throughout the organism and cannot be passed between generations. 57 
These results suggest that there are differences between the two pathways which 58 
remain to be discovered. 59 
Introduction 60 
RNA interference (RNAi) is a mechanism of gene silencing which is broadly 61 
conserved across eukaryotes. RNAi is initiated by cleavage of long double-stranded 62 
RNA (dsRNA) by the RNase III enzyme Dicer into short 20-24 nucleotide (nt) 63 
siRNAs (1). These siRNAs are bound by Argonaute proteins and act as a guide to the 64 
complementary mRNA, which is subsequently destroyed by the slicer action of the 65 
Argonaute protein (2). 66 
In C. elegans there is an additional amplification step to the pathway. siRNAs 67 
generated by Dicer (DCR-1) form complexes with Argonaute proteins which recruit 68 
RNA dependent RNA polymerases (RdRPs) to the target mRNA. The RdRPs produce 69 
an abundant class of siRNAs (3, 4), which are almost exclusively 22 nt and possess a 70 
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guanine (G) as the 5' nucleotide, hence are referred to as 22G-RNAs. 22G-RNAs are 71 
more abundant than siRNAs produced by Dicer and are required for effective gene 72 
silencing. However, they are not able to recruit RdRPs to the target, thus are unable to 73 
initiate generation of further 22G-RNAs (5).  74 
The exogenous RNAi pathway in C. elegans is systemic (6, 7). Uptake of double-75 
stranded RNA into the intestine by the transporter protein SID-2 and the transfer 76 
between cells by SID-1and SID-5 is capable of silencing gene expression in most 77 
tissues (8-11). The exact mobile RNA species remains elusive, but there is some 78 
evidence to suggest that dsRNA molecules (probably DCR-1 products) are mobile 79 
and can be exported and imported by proteins required for systemic RNAi (12). 80 
Silencing initiated by the exogenous RNAi pathway can spread not just within the 81 
treated animals, but also to their offspring in what is known as transgenerational 82 
inheritance (13-16). Transgenerational inheritance initiated by RNAi does not occur at 83 
every locus, and is not fully penetrant: i.e. not all offspring inherit the silenced 84 
phenotype. The mechanisms responsible for both the transmission and establishment 85 
of transgenerational silencing remain cryptic, although it seems that both small RNA 86 
pathways and chromatin modifiers are required (13-18).  87 
RNAi acts as a potent defense mechanism against viruses in plants and animals (19-88 
23). In plants, long viral dsRNA precursors are processed into 21 nt long siRNAs by 89 
Dicer-like 4 (24, 25). These 21 nt siRNAs are capable of moving from cell to cell and 90 
directing silencing in the recipient cell (26, 27). The spread of siRNAs ahead of viral 91 
infection confers resistance on recipient cells. 24 nt Dicer-like 3 products are also 92 
capable of systemic spreading (26, 28). Similarly, Drosophila also utilize a siRNA 93 
pathway in viral defence. In this case, both Dicer 2 and Argonaute 2 are required for 94 
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an effective antiviral response (29). Again, systemic spreading throughout the 95 
organism is important in antiviral immunity, although in this case it seems to be 96 
dsRNA molecules that are mobile (29). RNAi pathways have also recently been 97 
suggested to play a role in viral defence in mammals (20, 21), although to date it is 98 
not known if the antiviral silencing can spread between cells. 99 
The RNAi pathway also acts in viral defence in C. elegans. The initial trigger is a 100 
dsRNA viral replication intermediate that is recognized by DRH-1 (30). This 101 
recognition allows DCR-1 and accessory proteins to produce siRNAs and 102 
subsequently 22G-RNAs in a manner that appears to utilize the same pathway as 103 
classical RNAi gene silencing (19, 30-32): indeed the level of our current knowledge 104 
suggests that it is only the viral recognition factor DRH-1 that differs between the two 105 
pathways. 106 
 107 
Despite the similarities to the canonical RNAi pathway it is still unclear whether the 108 
C. elegans antiviral siRNA pathway gives rise to systemic effects. In the case of a 109 
virus that infects somatic cells such as the Orsay virus, indirect evidence to support 110 
systemic antiviral RNAi could be taken from transgenerational inheritance of 111 
silencing, since this implies that the RNAi response must have spread into the 112 
germline. Transgenerational silencing of a Flock House Virus transgene under the 113 
control of a heat shock promoter has been observed (33) however, this may occur as a 114 
result of the presence of the transgene in all cells of the animal. More recently, it was 115 
reported that parental exposure to Orsay virus can protect offspring from infection 116 
(34). However Guo and colleagues reported that sid-1 mutants are not any more 117 
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susceptible to Orsay virus infection than N2, suggesting that systemic RNAi is not 118 
important in viral defence (35). 119 
In this study, we test for the existence of a systemic RNAi response against the Orsay 120 
virus using a sensor for antiviral siRNA to report on the spread of antiviral silencing 121 
between cells. Suprisingly, in contrast to the exogenous RNAi pathway in C. elegans 122 
and viral defence pathways in both plants and Drosophila, we show that RNAi 123 
following infection with Orsay virus is not systemic. Consistently, we show that there 124 
is no transgenerational inheritance of Orsay virus-induced silencing. Together these 125 
results suggest partitioning between intermediates in RNAi induced by the Orsay 126 
virus and exogenous dsRNA and challenge the assumption that systemic RNAi 127 
evolved as an antiviral defense mechanism.  128 
Materials and Methods 129 
Genetics 130 
C. elegans were grown under standard conditions at 20 °C on HB101 bacteria unless 131 
otherwise indicated. The wild-type strain was var. Bristol N2 (36). Strains used in this 132 
study were: HC75 ccIs4251; sid-1(qt2), HC271 ccIs4251; qtIs3; sid-2(qt42); mIs11, 133 
RB2519 drh-1(ok3495), SX2836 mjIs242[psur-5::GFP::OrsayRNA2::tbb-2 + psur-134 
5::mCherry::unc-54], SX2839 mjIs242[psur-5::GFP::OrsayRNA2::tbb-2 + psur-135 
5::mCherry::unc-54]; sid-1(qt2), SX2838 mjIs242[psur-5::GFP::OrsayRNA2::tbb-2 136 
+ psur-5::mCherry::unc-54]; drh-1(ok3495), SX2813 mjEx565[psur-137 
5::GFP::OrsayRNA1::tbb-2]; mjEx566[psur-5::mCherry::unc-54] 138 
Molecular Biology 139 
Sensor generation 140 
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psur-5::GFP::OrsayRNA2::tbb-2 and psur-5::GFP::OrsayRNA1::tbb-2 141 
These constructs were generated using the MultiSite Gateway Three-fragment Vector 142 
Construction Kit (Life Technologies). psur-5 in the first position was a gift from the 143 
Ahringer laboratory, and GFP (cloned from pPD95.75) was placed in the second 144 
position. PCR fusion was used to generate the OrsayRNA::tbb-2 fragments which 145 
were placed in the third position. All three fragments were combined in an LR 146 
reaction into the pCFJ150 vector. Primer sequences for amplifying viral segments 147 
from cDNA are listed in Table S1 (available on request). 148 
Preparation of RNAi constructs 149 
Viral segments were PCR amplified from cDNA using primers with appropriate tails 150 
for BP cloning into pDONR221 (Gateway cloning). LR reactions were performed to 151 
place viral segments in a gateway modified RNAi vector L4440. Primer sequences are 152 
listed in Table S1 (available on request). 153 
Detection of viral infection 154 
Virus filtrate was prepared as described previously (19). 155 
Infection of strains of interest. For all strains, two or three young adults were 156 
inoculated with 20 µl of viral filtrate for 4 days at 20 °C in 55 mm plates. 157 
Detection of viral RNA. Four days after infection, all animals were collected in M9; 158 
RNA extraction and qRT-PCR was performed as described previously (19, 30). 159 
Aliquots of RNA were kept apart for small RNA libraries (see below). 160 
Comparison of infection methods 161 
Infection of strains of interest.  162 
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Liquid culture based infection: 200 L2s were rotated for 1 hour at 20 °C in 300 µl M9, 163 
100 µl HB101 in LB broth and 100 µl of Orsay Virus filtrate (non-diluted, or diluted 164 
in M9 10 or 100 times). After 1 hr, the animals were collected and washed three times 165 
in M9 before transfer to 50 mm plates. 166 
Agar based infection: 200 L2s were transferred to a 50 mm plate per individual 167 
infection. 100 µl of Orsay Virus filtrate was added (non-diluted, or diluted in M9 10 168 
or 100 times). 169 
Infections were performed in five biological replicates. 170 
Detection of viral RNA. For all strains 200 L2 animals were infected and collected 48 171 
hours post-infection for detection of viral RNA as described above. 172 
RNAi 173 
RNAi bacteria were grown for 6 hr with shaking at 37 °C. Bacteria were then seeded 174 
onto 55 mm NGM plates containing IPTG (1 mM) and carbenicillin (25 µg/ml). After 175 
drying overnight, 2-3 animals were added and then grown at 20 °C for 4 days, at 176 
which point they were either collected for RNA extraction (for measuring Orsay viral 177 
load, or for small RNA sequencing), or their phenotype was scored (for the viral 178 
sensor experiments). For the analysis of phenotype of animals treated with RNAi 179 
against unc-22 (ZK617.1) or dpy-11 (F46E10.9) genes (37), 5 plates of 4 L4 animals 180 
were plated on RNAi plates against the relevant gene and the progeny grown up on 181 
the same plates. Adult animals were then transferred onto non-RNAi plates and the 182 
progeny were scored for the phenotype to measure the percentage of animals 183 
displaying the phenotype. The experiment was repeated in triplicate. 184 
Small RNA sequencing 185 
RNA extraction, library preparation and sequencing 186 
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Extraction of RNA for libraries, library preparation and sequencing was performed as 187 
described previously (30). P0 animals were grown at 20 °C on 3 10 cm plates and 188 
collected as a mixed stage population of predominantly adults 4 days after viral 189 
infection or RNAi treatment. F1s were obtained by bleaching of P0s, and assayed at 190 
three different ages – as embryos (immediate collection), after 24 hr or 72 hr. P0 191 
infection was performed in biological duplicates, with one replicate used for the 192 
embryos, and the other used for both 24 hr and 72 hr timepoints. P0 replicates were 193 
compared to ensure equality. 194 
Sequencing analysis. Small RNA libraries were sequenced using the Illumina MiSeq 195 
and/or HiSeq. Processing and alignment of high-throughput sequencing data to the 196 
Orsay virus was carried out as described previously, using Bowtie for all sequence 197 
alignments allowing up to one mismatch to compensate for divergence in the viral 198 
sequence (30). To generate plots of small RNAs aligning to unc-22 and dpy-11 coding 199 
sequences in fasta format for dpy-11 and unc-22 genes were downloaded from 200 
wormbase (WS236) and were used to build genomes using Bowtie-build to which 201 
small RNAs were aligned allowing 0 mismatches.   202 
 203 
Results 204 
Weak transgenerational transmission of antiviral siRNAs. 205 
Exposing C. elegans to dsRNA through feeding, injection or viral infection, results in 206 
the generation of two classes of siRNAs that bring about RNAi (Fig 1A). The first 207 
class of siRNAs are generated by DCR-1 activity on dsRNA, possess 5'  208 
monophosphates, have a modal length of 23 nucleotides (nt) and no overall first 209 
nucleotide bias. The second class of siRNAs (22G-RNAs) are generated by the 210 
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activity of RNA dependent RNA polymerase and have 5' triphosphates, with a strong 211 
preference for G at the first nucleotide. Standard small RNA library preparation 212 
cannot detect 22G-RNAs unless the 5' triphosphate is removed by enzymatic 213 
treatment. We performed polyphosphatase treatment of the RNA before library 214 
preparation, which enables the detection of both direct Dicer products and 22G-215 
RNAs.  216 
To better understand the antiviral RNAi response we used high-throughput 217 
sequencing to assess the small RNAs present in biological duplicates of N2 animals 218 
infected with Orsay virus (N2 P0) and compared with their uninfected offspring (N2 219 
F1)(Fig 1B-E) (raw data available from GEO accession number GSE60020). As 220 
shown previously (30) the N2 P0 sample (Fig 1B) shows Dicer products mapping 221 
both sense and antisense to the viral genome and abundant 22G-RNAs mapping 222 
antisense to the viral RNA. There are considerably less viRNAs in F1 animals than 223 
their parents and they decrease over time (Fig 1 C-E, Fig 2A). 224 
To get an idea of how these very low levels of inherited viRNAs compared to 225 
inheritance following exogenous RNAi, we also prepared libraries from animals 226 
feeding on RNAi food against the endogenous loci dpy-11 (Fig 1F-I) and unc-22 (Fig 227 
1J-M), and their offspring who were fed on standard HB101 bacteria. Both the dpy-11 228 
and unc-22 genes are expressed in somatic cells; however, the dpy-11 phenotype 229 
conferred by RNAi can be inherited into the F1 generation whilst the unc-22 230 
phenotype cannot (Fig 2B) (38). siRNAs complementary to both dpy-11 and unc-22 231 
were approximately as abundant as viRNAs in infected P0 animals (Fig1 F,J). Both 232 
dpy-11 and unc-22 siRNAs were retained to considerably higher levels than the 233 
viRNAs in the F1 offspring (Fig 2A). Notably 22G-RNAs are still clearly visible in 234 
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the offspring of both unc-22 and dpy-11 treated animals at all time points sampled; 235 
dpy-11 22G-RNAs were higher than unc-22 22G-RNAs consistent with the 236 
inheritance of the dpy-11 phenotype. Thus the viral siRNAs are inherited into the F1 237 
generation at a reduced level compared to endogenous, somatically expressed loci, 238 
even those for which a phenotype is not detected in the F1. 239 
No evidence for a protective “vaccination” effect in F1s 240 
The fact that viRNAs appear to be inherited at such low levels strongly suggested that 241 
they would be unable to protect against future viral infection in the F1 generation. To 242 
test this directly we grew wild-type animals in the presence or absence of virus, 243 
“bleached” them to remove infected P0 animals and the Orsay virus from the culture, 244 
and then reinfected the F1 generation. If the small number of inherited viRNAs could 245 
protect against viral infection in the subsequent generation we would expect to see 246 
lower levels of viral replication in the offspring of infected parents compared to 247 
uninfected parents. We detected viral load in F1 animals four days after infection by 248 
qPCR for Orsay RNA. There was no difference in Orsay RNA levels between the 249 
animals whose parents had been exposed to Orsay virus and those with no prior 250 
exposure (Fig 2C, D). These results suggest that the few viRNAs detected in the F1 251 
generation are insufficient to induce viral silencing. This lack of F1 “vaccination” by 252 
the Orsay virus contrasts with recently published work by Sterken et al. (34). One 253 
main difference between the two studies is the infection procedure – infection in 254 
liquid culture for 1 hour, followed by growth on agar (Sterken) vs infection and 255 
growth on agar (this study). It is plausible that liquid based infection may result in 256 
higher levels of viral infection and thus make F1 “vaccination” possible. To address 257 
this issue we tested the levels of infection produced by the two methods in both N2 258 
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and drh-1 animals and found that agar-based infection was more reproducible and 259 
resulted in higher levels of infection than liquid culture based infection over a range 260 
of viral concentrations (Fig 2E). 261 
Generation of an antiviral 22G sensor to detect viral infection 262 
To try and understand the reasons for the failure of viRNAs to be inherited into the F1 263 
generation we developed a GFP sensor capable of detecting antiviral 22G-RNAs. The 264 
sensor consists of an integrated, multi-copy transgenic array of the ubiquitous sur-5 265 
promoter driving GFP expression, followed by approximately 600bp of Orsay RNA2 266 
before the tbb-2 3’ UTR (psur-5::GFP::OrsayRNA2::tbb-2). The animals also carry 267 
the same promoter driving mCherry expression with an alternate 3’UTR (psur-268 
5::mCherry::unc-54) (Fig 3A). In this system uninfected animals should express both 269 
GFP and mCherry, resulting in “orange” animals. Upon Orsay virus infection, 270 
viRNAs produced in the infected cells should silence the GFP transgene resulting in 271 
red cells. As RNAi is systemic in C. elegans, the mobile silencing signal generated 272 
after or during the dicing of viral dsRNA should spread systemically through the 273 
organism. When, in an uninfected cell, the mobile species encounters the mRNA 274 
produced from the sensor transgene the mobile signal should trigger the production of 275 
22G-RNAs and silence the sensor (Fig 3B). 276 
GFP and mCherry expression in uninfected animals is ubiquitous, but predominately 277 
intestinal (Fig 3C). To confirm that the sensor is responsive to silencing in all cells we 278 
performed RNAi against GFP or against the Orsay RNA2 fragment. This treatment 279 
silences the sensor robustly in all animals, with residual GFP expression in the 280 
pharynx only (the pharynx is known to be somewhat RNAi resistant) (Fig 4), 281 
confirming that exogenous RNAi silences this sensor systemically. Surprisingly, 282 
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however, when we exposed these sensor animals to the Orsay virus, GFP silencing 283 
was not observed systemically: although 40% of animals displayed at least one 284 
silenced intestinal cell, less than 3% failed to silence all intestinal cells (Fig 3D).  285 
Orsay virus infection does not produce a mobile siRNA signal 286 
Given the limited ability of the antiviral RNAi response generated against the Orsay 287 
virus to spread between cells, we hypothesized that systemic RNAi may not be 288 
important in defending against viral infection. Supporting this view, Guo et al. 289 
recently reported results suggesting that indeed Orsay virus levels accumulated to 290 
similar levels in N2 and a sid-1 mutant (35). We confirmed this result, and 291 
additionally showed that sid-2 is dispensable for viral defence (Fig 5A). In order to 292 
further study the role of sid-1 in viral defence we assayed the siRNAs present in 293 
Orsay infected animals and their offspring by small RNA sequencing as described 294 
above for N2 animals (Fig 5B,C). We could detect no difference in small RNAs 295 
between the sid-1 strain and N2, further confirming that sid-1 transport of mobile 296 
siRNAs is not required for their generation in the context of Orsay virus infection.  297 
If RNAi is not moving from cell-to-cell during infection with the Orsay virus, cases 298 
where we observe sensor silencing in more than one cell would only occur due to the 299 
virus directly infecting each cell. To test this hypothesis we crossed the sensor into the 300 
drh-1 background, which displays increased susceptibility to viral infection (Fig 6A). 301 
drh-1 sensor animals displayed an increased number of animals with many silenced 302 
cells (Fig 6C), suggesting that silencing of the sensor is driven by infection rather than 303 
mobile RNAi. While drh-1 animals are defective in the production of antiviral 304 
siRNAs, they do produce them at low levels (30), enough to silence the sensor in 305 
infected cells.  306 
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 To test the lack of cell-to-cell spreading further we crossed the sensor into the 307 
sid-1 background. As sid-1 are as susceptible to viral infection as N2 (Fig 5A), there 308 
should be no difference between the number of silenced cells within individual 309 
animals between N2 and sid-1 sensor animals. However, when we crossed the sensor 310 
into sid-1 mutants (Fig 6B) there was a significant change in the number of animals 311 
with multiple silenced cells in the sid-1 background compared to N2 (Fig 6C). This 312 
might indicate that a low level of spreading of silencing from one cell to its direct 313 
neighbour does occur in N2. To address this issue in all three strains we followed 314 
eight partially silenced animals individually over three days and the GFP silencing 315 
never became systemic (Fig 7). Over the three days that we followed the N2 and sid-1 316 
sensor animals the number of GFP silenced cells rarely changed, indicating that if 317 
there is a silencing signal passing from one cell to another it happens very slowly or 318 
infrequently. In the drh-1 background the number of silenced cells increased in more 319 
than half of the animals over the three day period. Although not significantly different 320 
to N2, this trend is consistent with an increased number of infected cells due to the the 321 
higher levels of infection known to be sustained in this background (30). 322 
Taken together these results indicate that, unlike in exogenous RNAi, viral infection 323 
does not result in large numbers of dsRNA intermediates able to be trafficked by sid-324 
1. 325 
Orsay-derived transgenes are not sufficient to enable inheritance of antiviral siRNAs 326 
against the Orsay virus 327 
The lack of inheritance of the antiviral RNAi response against the Orsay virus was 328 
surprising given that Flock house virus transgene silencing was reported to be 329 
transgenerationally inherited (33). One explanation for this discrepancy could be that 330 
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the Flock house virus transgene is carried in all cells, whilst the Orsay virus only 331 
infects intestinal cells. Transgenerational silencing might therefore not occur in the 332 
Orsay virus because there is a requirement for a template, either RNA or DNA, in the 333 
germline in order to transmit a silencing signal. To test this, we asked whether Orsay 334 
virus infection could transmit silencing of the viral sensor transgene, carried in all 335 
cells, into the next generation.  336 
First, we tested whether RNAi induced silencing against either GFP or the Orsay 337 
RNA2 fragment in the P0 generation could result in transgenerational sensor 338 
silencing. We subjected P0 Orsay RNA2 sensor animals to RNAi treatment with 339 
either GFP or Orsay RNA2. Either treatment results in complete sensor silencing as 340 
described previously (Fig 4). Adults were then removed from the RNAi treatment and 341 
the phenotype of the resultant F1 progeny scored after 4 days. Both treatments 342 
resulted in silencing of the GFP transgene in the F1 generation (Fig 8A), showing that 343 
the sensor is capable of being silenced in a transgenerational manner. 344 
To test for transgenerational silencing of the sensor following Orsay virus exposure, 345 
we scored the GFP status in the offspring of eight animals that themselves displayed 346 
partial sensor silencing (and were thus infected with Orsay virus). Orsay virus is not 347 
transmitted vertically (19), so the only virus present on these plates is that carried 348 
within the parent. We performed this experiment in the wildtype sensor, sid-1 and 349 
drh-1 genetic backgrounds. The offspring of wildtype and sid-1 infected parents 350 
showed almost no GFP silencing (and were not significantly different from each 351 
other), whereas drh-1 F1 animals showed significantly more GFP silencing compared 352 
to the wildype sensor (p<0.001) (Fig 8B). These data are consistent with no 353 
inheritance of transgene silencing following viral infection in any genotype and 354 
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horizontal transmission of viral infection and thus de novo sensor silencing in the case 355 
of drh-1. 356 
No protection against infection with the Orsay virus in the F1 generation following 357 
RNAi 358 
We have shown that exposure of parents to the Orsay virus does not confer resistance 359 
in F1 progeny and that Orsay virus-induced sensor silencing does not seem to be 360 
inherited. RNAi-induced silencing against the viral sensor can however be passed on 361 
to the F1 generation, so therefore we asked whether RNAi-induced silencing in the 362 
presence of the Orsay sensor could protect against Orsay virus in the P0 generation, or 363 
provide protection against Orsay virus infection in F1 offspring. 364 
We tested a series of regions of the Orsay RNA genome for their ability to protect 365 
against Orsay virus replication in RNAi feeding experiments (Fig 8C). Intriguingly, 366 
Orsay levels were most affected after RNAi against Orsay RNA1 compared with 367 
Orsay RNA2 (Fig 8D). This difference in RNAi efficacy between RNA1 and RNA2 368 
could be due to the fact that RNA1 encodes the RNA dependent RNA polymerase and 369 
RNA2 the capsid protein. RNAi against the RdRP is more likely to have a direct 370 
effect on viral RNA accumulation within infected cells than RNAi against the capsid, 371 
which is more likely to affect later steps of the viral life cycle such as assembly. 372 
We then asked whether there was also a reduction in Orsay RNA levels following 373 
concurrent RNAi and viral infection in N2 or an Orsay sensor background (Fig 8E). 374 
Because viral levels were most significantly altered in animals feeding on RNAi 375 
clones targeting RNA1 rather than RNA2, for this experiment we used an Orsay 376 
RNA1 sensor instead of the previously used Orsay RNA2 sensor. The sensor was 377 
extrachromosomal instead of integrated but otherwise identically constructed. 378 
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Interestingly, while Orsay RNAi reduced the levels of Orsay RNA detected in N2, the 379 
presence of the RNA1 sensor resulted in even more RNAi-induced protection against 380 
Orsay replication (Fig 8F). It is tempting to speculate that this sensor-associated 381 
RNAi “boost” is due to the presence of siRNA molecules (generated from the sensor) 382 
already in the cell before the viral entry, thus enabling immediate viral RNA 383 
destruction. 384 
To test whether the combination of RNAi against the Orsay virus and the sensor could 385 
confer protection in the F1 offspring we bleached the adults from the previous 386 
experiment to generate uninfected embryos and then infected them with the Orsay 387 
virus (Fig 8E). Despite the large difference in Orsay infection levels between RNAi 388 
treated and non-treated sensor animals in the P0 generation, there was no difference in 389 
the infection levels of their offspring (Fig 8G, grey). There was also no difference in 390 
viral infection levels in the N2 F1 offspring of parents fed on either empty or RNA1 391 
RNAi (Fig 8G, black). 392 
These data show that even in the most extreme case of RNAi and a transgenic viral 393 
portion, there is still no evidence for deposition into the F1 offspring of functional 394 
small RNA molecules that can protect against Orsay virus infection. 395 
Discussion 396 
Two of the most notable aspects of the siRNA pathway in C. elegans initiated in 397 
response to exposure to dsRNA matching endogenous genes are its ability to spread 398 
throughout the animal and its ability to act transgenerationally. There has been much 399 
speculation on what the function of these properties is for animals in the wild, with 400 
the proposed role of RNAi in antiviral silencing a key candidate. Here we have shown 401 
that infection of C. elegans with the Orsay virus instigates neither transgenerational 402 
18 
 
nor systemic silencing. In the absence of any other known naturally occurring 403 
C. elegans virus, it is possible that systemic RNAi may function in defense against an 404 
as yet undiscovered infection.  Nevertheless our results have important implications 405 
both for the mechanism of systemic RNAi and the biology of small RNA pathways in 406 
C. elegans.  407 
 The fact that antiviral siRNA induced by Orsay virus infection, in contrast to 408 
siRNA induced by exposure to dsRNA, does not spread between cells may be 409 
explained by differences in the intermediates produced by the two pathways. 410 
Importantly, 22G-RNAs, produced by both pathways, are unlikely to transfer RNAi in 411 
C. elegans (12), perhaps because they cannot themselves trigger production of further 412 
22G-RNAs in somatic cells (5, 39). However, there is evidence that a small RNA 413 
species generated by the activity of Dicer/RDE-4 in response to dsRNA generated 414 
from endogenous genes or taken up from the environment is able to spread between 415 
cells (12). Both RDE-4 and Dicer are active on viral dsRNA, thus their activity must 416 
somehow be different when acting on viral dsRNA as compared to other sources of 417 
dsRNA. It is possible that this difference might be due to the requirement of DRH-1 418 
specifically for activity on viral dsRNA, perhaps reflecting a different subcellular 419 
localization of the DRH-1/Dicer complex. An alternative possibility is that the Orsay 420 
virus itself prevents systemic RNAi. Such a situation is well known to occur in plant 421 
viruses, many of which encode suppressors of silencing that prevent cell-to-cell 422 
spreading of silencing (40). Further work will be required to distinguish between 423 
these two possibilities. 424 
 Our observations on the non-systemic nature of the antiviral RNAi response to 425 
infection with the Orsay virus are fully consistent with the fact that we detected no 426 
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transgenerational protection against infection, and did not detect a strong small RNA 427 
signal mapping to the virus in the embryos derived from infected individuals. This is 428 
in contrast to robust inheritance of both small RNAs and the silencing phenotype in 429 
the case of RNAi-induced silencing of the dpy-11 gene and inheritance of small 430 
RNAs, albeit without an observable phenotype, in silencing of the unc-22 gene. The 431 
lack of systemic RNAi after infection with the Orsay virus thus prevents small RNAs 432 
from entering the embryos to sufficient extent to transmit the silencing effect. 433 
 The function of RNAi in antiviral defense in plants, fungi and animals, 434 
including mammals, has led to the proposal that viral infection was the major driving 435 
force behind its evolution. Systemic silencing, which potentially allows the antiviral 436 
siRNAs to move ahead of the spread of virus, and transgenerational vaccination of the 437 
next generation might seem to be ideal components of an effective antiviral pathway. 438 
It is therefore interesting that neither of these two aspects of the C. elegans RNAi 439 
pathway are employed in targeting the Orsay virus, despite an absolute requirement 440 
for cell-autonomous RNAi in antiviral defense. It remains possible that other naturally 441 
occurring viruses will be discovered which can instigate systemic or transgenerational 442 
responses, in particular viruses that could infect the germline or DNA viruses, which, 443 
in plants, appear to be targeted by transgenerational silencing through RNA-directed 444 
DNA methylation. It is also possible that, as noted above, the Orsay virus itself could 445 
have evolved to prevent systemic silencing, although it is worth noting that the RNAi-446 
competent strain N2 is unlikely to be the natural host of the Orsay virus. Orsay virus 447 
was discovered in the strain JU1580, which is deficient for antiviral RNAi (19, 30): 448 
thus there may not have been strong selective pressure to evolve resistance to 449 
systemic silencing in this virus. However, it remains an interesting possibility that 450 
systemic RNAi in C. elegans evolved for completely different reasons, linked 451 
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potentially to its unusual ability to take up dsRNA from its environment. The answers 452 
to these questions will require deeper sampling of C. elegans in its natural 453 
environment to understand better the selective forces acting on the RNAi pathway in 454 
the wild. 455 
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 582 
Figure Legends 583 
Figure 1. Deep sequencing of viRNAs after Orsay virus infection and RNAi. (A) 584 
Cartoon showing the pathway of 23 nt Dicer product and 22G production in 585 
C. elegans. (B-M) 5' independent small RNA sequencing of P0 and F1 animals after 586 
either Orsay virus exposure (B-E) or the indicated RNAi treatment (F-M). P0 animals 587 
were assayed as a mixed stage population of predominantly adults, and F1s were 588 
synchronized and assayed at three different ages as indicated. Data are shown as sense 589 
or antisense and ordered according to the size of the RNA molecule. Y axis is reads 590 
per million. 591 
Figure 2. No evidence for inheritance of viRNAs after Orsay virus infection. (A) 592 
Shown are the 23 nt sense (left) Dicer products and 22G antisense (right) secondary 593 
RNAs from Figure 1 normalized to library size and the level in the P0 generation. (B) 594 
Shown is the percentage of P0 and F1 animals displaying dpy or unc phenotype 595 
following exposure to RNAi. Error bars show the standard deviation from three (P0) 596 
or four (F1) biological replicates. ** p<0.005, t-test. (C) The experimental design for 597 
the data shown in (D). (D)  qRT-PCR data for the relative levels of Orsay virus four 598 
days after exposure in animals whose parents were either infected (+V+V) or 599 
uninfected (-V+V) with Orsay virus (Orsay infection of parents was confirmed by 600 
qRT-PCR). Data were normalized to gapdh levels and the level of infection in the +V 601 
parents. Error bars show the SEM. (E) This graph shows a comparison between Orsay 602 
virus infection levels between liquid and agar-based infection protocols in both drh-1 603 
and N2 strains with three different concentrations of virus. Each condition was 604 
performed with 5 biological replicates and error bars represent the SEM. 605 
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Figure 3. Development of a viRNA sensor. (A) Schematic of viRNA sensor. (B) 606 
Cartoon showing the expected phenotype of sensor animals in the absence of Orsay 607 
virus (top), and the presence of Orsay virus with (middle) or without (bottom) 608 
systemic silencing. Yellow indicates both GFP and mCherry expression. Red 609 
indicates only mCherry expression. (C) Orsay sensor showing representative 610 
uninfected (left panel) and infected (right panel) animals. Infected and uninfected 611 
animal images were taken at the same intensity. (D) The percentage of sensor animals 612 
showing the indicated amount of silenced cells in the absence (grey) or presence 613 
(black) of Orsay virus. Error bars indicate the SEM for six biological replicates. 614 
Figure 4 Orsay sensor with RNAi. Orsay sensor showing representative animals 615 
treated with the indicated RNAi clone. All images were taken at the same intensity. 616 
Figure 5. sid-1 and sid-2 are not required for viral resistance. (A) qRT-PCR 617 
showing the relative levels of Orsay virus four days after infection in N2, drh-1, sid-1 618 
and sid-2. drh-1 animals show significantly higher levels of Orsay virus RNA than N2 619 
(p<0.05, t-test), but there is no significant difference between either sid-1 or sid-2 and 620 
N2. Data were normalized to gapdh and then N2. (B) Shown are the 23 nt sense (left) 621 
Dicer products and 22G antisense (right) secondary RNAs from (C) (sid-1) and Figure 622 
1 (N2) normalized to library size and the level in the P0 generation. (C) 5’ 623 
independent small RNA sequencing of P0 and F1 sid-1 animals after either Orsay 624 
virus exposure. P0 animals were assayed as a mixed stage population of 625 
predominantly adults, and F1s were synchronized and assayed at three different ages 626 
as indicated. Data are shown as sense or antisense and ordered according to the size of 627 
the RNA molecule. Y axis is reads per million. The 5’ nucleotide is indicated by 628 
colour. Red = A, green = C, blue = G and pink = U. (D)  629 
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Figure 6. Orsay sensor in sid-1 and drh-1 backgrounds. (A, B) Orsay sensor 630 
showing representative uninfected (left panel) and infected (right panel) animals. 631 
Infected and uninfected animal images were taken at the same intensity. (C) The 632 
percentage of sensor N2 (light grey), sid-1 (grey) or drh-1 (black) animals showing 633 
the indicated amount of silenced intestinal cells in the presence of Orsay virus. The 634 
amount of intestinal cell silencing differs significantly between both the sid-1 and 635 
drh-1 backgrounds and the wildtype background (p< 0.001 in both cases. Fishers 636 
exact test). Error bars represent the SEM over six biological replicates. 637 
Figure 7. No systemic sensor silencing following Orsay virus. Horizontal blocks 638 
indicate individual infected animals followed over three days – 5 (black), 6 (light 639 
grey) and 7 (dark grey) dpi. The x axis indicates the percentage of the animal 640 
silenced. Eight animals each were followed for N2 (A), sid-1 (B) and drh-1 (C). 641 
Figure 8. RNAi-induced Orsay virus silencing. (A) This graph shows the 642 
percentage of F1 animals with inherited sensor silencing after parental exposure to 643 
feeding RNAi against either Empty vector (black), GFP (light grey) or Orsay RNA2 644 
(dark grey). Error bars represent the SEM for two biological replicates. (B) Sensor 645 
silencing in the F1 offspring of infected animals (as judged by sensor silencing). The 646 
x axis shows the percentage of N2 (light grey), sid-1 (dark grey) and drh-1 (black) 647 
animals with the indicated amount of sensor silencing in the intestine. *** p< 0.0005, 648 
Fishers exact test. (C) Cartoon showing the position on the Orsay genome of the 649 
RNAi clones used in D. and the position of the qPCR amplicons (D) This graph 650 
shows the relative levels of Orsay virus (4 dpi) as measured by qRT-PCR in N2 651 
animals fed with the indicated RNAi clone. Error bars represent the SEM for n=3 652 
(R1-1, R1-2, R2-1), n=6 (R1-3, R1-4, R2-2, R2-3) or n=12 (empty) biological 653 
replicates (E) Schematic illustrating the experimental design to test for the presence or 654 
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absence of viral resistance in the F1 generation caused by previous viral exposure, 655 
viral RNAi, or both. (F) This graph shows the relative Orsay virus levels measured by 656 
qRT-PCR in P0 animals 4 days after Orsay virus exposure. Animals were either 657 
wildtype or carried an Orsay RNA1 sensor transgene and were exposed to either 658 
empty vector or Orsay RNA1 RNAi. Exposure to Orsay RNAi in the P0 generation 659 
causes resistance to Orsay viral infection in both genetic backgrounds, although the 660 
effect is more significant in the sensor background. Data were normalized to gapdh 661 
and then N2 empty vector. * indicates P<0.05 *** indicates P<0.0005, t-test. Error 662 
bars represent the SEM for three biological replicates. (G) Relative Orsay RNA1 663 
levels in F1 animals. The x-axis shows the RNAi treatment and/or Orsay exposure of 664 
their parents. N2 animal are shown in black and RNA1 sensor animals in light grey. 665 
There is no significant difference between any treatment or strain. Data were 666 
normalised to gapdh and then N2 F1 empty vector. Error bars represent the SEM for 667 
three biological replicates. 668 








